Both in Pharmaceuticals
Evommune vs Nature's Sunshine Products
Over the past year EVMN returned −68.8% and NATR returned −9.3%; their daily moves had a correlation of -0.06.
EVMN −68.8% NATR −9.3%Growth of $1, one year, split-adjusted
| Metric | EVMN | NATR |
|---|---|---|
| Price | $6.36 | $12.37 |
| Market cap | $230.8M | $217.7M |
| Today | +23.25% | −0.13% |
| 1 month | −23.8% | −3.0% |
| 6 months | −73.3% | −54.2% |
| Year to date | −62.9% | −42.7% |
| 1 year | — | −10.1% |
| Revenue growth (YoY) | — | +1.9% |
| Gross margin | — | 73.7% |
| Net margin | — | 3.0% |
| P/E (TTM) | — | 12.0× |
| Price / sales | — | 0.4× |
| Net cash | $200.4M | $82.5M |
| Dividend yield | — | — |
| Volatility (60d) | 85.0% | 48.1% |
| Short % of float | 16.5% | 6.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).